Description

SHORT DESCRIPTION:

GliaPharm is a biotechnology business established in Switzerland that focuses on neurological and mental illnesses. In pathological settings, GliaPharm’s novel treatment approach is to target glial cells, the’support cells’ of neurons, to maintain and boost brain metabolism. Our goal is to establish a premier biotechnology firm focused on glia-mediated pathways as neuroprotection and cognitive function maintenance agents.

 

LONG DESCRIPTION:

Based in
Founded in

2016

Founding Status

$ 1 Million - $ 2.5 Millions

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected